ROLE OF [-2]proPSA AND ITS DERIVATIVES IN PROSTATE CANCER SCREENING IN MEN WITH A TOTAL PROSTATE-SPECIFIC ANTIGEN LEVEL OF 2-10 NG/ML
- Authors: Nevlrovlch E.1, Yakovenko A.1, Rumyantsev A.1, Sellvanov A.2, Budylev S.2
-
Affiliations:
- Acad. I.P. Pavlov First Saint Petersburg State Medical University
- City Hospital Thirty-One, Saint Petersburg
- Issue: Vol 27, No 6 (2016)
- Pages: 67
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/116710
- ID: 116710
Cite item
Open Access
Access granted
Abstract
The efficiency of using [-2]proPSA and its derivative a p2PSA to free prostate-specific antigen (PSA) ratio (%p2PSA) for the early detection of prostate cancer in men with a total prostate-specific antigen level of 2 to 10 ng/ml.
Keywords
Full Text
About the authors
E. Nevlrovlch
Acad. I.P. Pavlov First Saint Petersburg State Medical University
A. Yakovenko
Acad. I.P. Pavlov First Saint Petersburg State Medical University
A. Rumyantsev
Acad. I.P. Pavlov First Saint Petersburg State Medical UniversityProfessor
A. Sellvanov
City Hospital Thirty-One, Saint Petersburg
S. Budylev
City Hospital Thirty-One, Saint Petersburg
Email: b31@zdrav.spb.ru
References
- Алексеев С.М., Прощаев К.И., Ильницкий А.Н. и др. Потенциальное влияние старческой астении на риск возникновения осложнений химиотерапии у пожилых больных // Современные проблемы науки и образования. -2014; 3: URL: www.science-education.ru/117-13193
- Чиссов В.И., Русаков И.Г. Заболеваемость раком предстательной железы в Российской Федерации // Эксперим. и клин. урол. - 2011; 2-3: 6-7.
- Schroder F., Hugosson J., Roobol M. et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up // Lancet. - 2014; 384 (9959): 2027-35.
- Mikolajczyk S., Marker K., Millar L. et al. A truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancer // Cancer Res. - 2001; 61 (18): 6958-63.
- Jansen F., Roobol M., Jenster G. et al. Screening for prostate cancer in 2008 II: the importance of molecular subforms of prostate-specific antigen and tissue kallikreins // Eur. Urol. - 2009; 55 (3): 563-74.
Supplementary files
